Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC boosted its holdings in Doximity, Inc. (NASDAQ:DOCS) by 10.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 7,251 shares of the company’s stock after buying an additional 672 shares during the period. Sanctuary Advisors LLC’s holdings in Doximity were worth $428,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Shaker Investments LLC OH purchased a new position in shares of Doximity in the 4th quarter valued at $559,000. Fountainhead AM LLC purchased a new position in Doximity in the third quarter valued at about $710,000. Penserra Capital Management LLC acquired a new position in shares of Doximity during the third quarter worth about $2,384,000. Principal Financial Group Inc. boosted its position in shares of Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock worth $15,695,000 after buying an additional 4,282 shares during the period. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of Doximity in the fourth quarter valued at about $362,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 37.40% of the stock is owned by company insiders.

Analysts Set New Price Targets

DOCS has been the topic of several recent research reports. Mizuho boosted their price target on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. The Goldman Sachs Group boosted their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Bank of America lifted their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Raymond James reissued an “outperform” rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Finally, Barclays lifted their target price on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research report on Monday, November 11th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Stock Performance

Doximity stock opened at $70.44 on Monday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The firm’s 50-day moving average is $61.91 and its 200-day moving average is $50.72. The company has a market cap of $13.15 billion, a P/E ratio of 70.44, a PEG ratio of 4.10 and a beta of 1.39.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.